Haemonetics Corporation Total Debt 2009–2026
Haemonetics Corporation reported $1.24B of total debt (short- plus long-term borrowings) for fiscal 2026. That was 1.2% higher than fiscal 2025. Compared with fiscal 2021, the change was +79.5%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2026 | $1.24B | +1.2% |
| FY 2025 | $1.22B | +53.6% |
| FY 2024 | $797.56M | +5.8% |
| FY 2023 | $754.10M | +34.8% |
| FY 2022 | $559.44M | -19.0% |
| FY 2021 | $690.59M | +126.0% |
| FY 2020 | $305.51M | -5.3% |
| FY 2019 | $322.45M | +442.6% |
| FY 2018 | $59.42M | -81.2% |
| FY 2017 | $315.81M | -22.7% |
| FY 2016 | $408.46M | -5.1% |
| FY 2015 | $430.48M | -2.2% |
| FY 2014 | $440.29M | -9.3% |
| FY 2013 | $485.69M | +12779.7% |
| FY 2012 | $3.77M | -22.7% |
| FY 2011 | $4.88M | +9.4% |
| FY 2010 | $4.46M | — |
| FY 2009 | $0 | — |
Source: Haemonetics Corporation SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HAE 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Haemonetics Corporation reported $1.24B of total debt (short- plus long-term borrowings) for fiscal 2026. That was 1.2% higher than fiscal 2025. Compared with fiscal 2021, the change was +79.5%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Haemonetics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHaemonetics Corporation — frequently asked questions
What is Haemonetics Corporation's total debt (short- plus long-term borrowings)?
Haemonetics Corporation (HAE) reported total debt (short- plus long-term borrowings) of $1.24B for fiscal year 2026, per its SEC filings.
Where does this data come from?
Figures are computed from Haemonetics Corporation's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More HAE financial history
Full HAE fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →